Hospital for Special Care

New Britain, Connecticut 06503

3 studies enrolling now · 27 studies all time

What they study most

ALS, Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Charcot-Marie-Tooth Disease, Chronic Obstructive Pulmonary Disease (COPD), Essential Tremor, Motor Neuron Disease, Muscle Spasticity, Myasthenia Gravis, Parkinson Disease Psychosis, Pulmonary Disease, Chronic Obstructive, Spinal Cord Injury

Studies at this site

• PREVENT ALL ALS Study — Recruiting now
• ASSESS ALL ALS Study — Recruiting now
• HEALEY ALS Platform Trial - Master Protocol — Running, not enrolling
• Scalable Expanded Access With Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS — Available (expanded access)
• Intermediate-Sized Expanded Access Study — NO_LONGER_AVAILABLE
• A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral Sclerosis (Pridopidine EAP 2) — NO_LONGER_AVAILABLE
• Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients — Status unconfirmed
• Prospective Study for Symptomatic Relief of ET With Cala Therapy — Completed
• Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS) — Completed
• Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension — Stopped early
• Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS — Completed
• Phase 3 Extension Study of Dexpramipexole in ALS — Stopped early
• The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study — Stopped early
• A Study for Patients Who Completed VITALITY-ALS (CY 4031) — Completed
• Phase 3 Study of Dexpramipexole in ALS — Completed
• A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS) — Completed
• Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year — Completed
• A Study of CK-2127107 in Patients With Spinal Muscular Atrophy — Completed
• Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS) — Completed
• Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis — Stopped early
• Dose Titration Study to Test Safety and Effects of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS) — Completed
• A Study to Assess the Safety and Effectiveness of FLX-787 in Subjects With Charcot-Marie-Tooth Disease Experiencing Muscle Cramps. — Stopped early
• A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps. — Stopped early
• Dose Finding Study in COPD — Completed
• Safety and Efficacy of Oral Fampridine-Sustained Release (SR) for the Treatment of Spasticity Resulting From Spinal Cord Injury — Completed
• Clinical Trial Ceftriaxone in Subjects With ALS — Completed
• Sodium Pyruvate Therapy in COPD Patients — Completed